This year’s RSNA meeting will see women’s imaging research focused on personalized patient care, including in screening, diagnostic, and interventional radiology.
Attendees ranging from general radiologists to breast imaging specialists to technologists will benefit from the many scientific and educational sessions that they can take back to their practices. Research on modalities ranging from ultrasound and MRI to molecular breast imaging and contrast-enhanced mammography (CEM) will be presented at the meeting.
AI’s potential will also be on display for attendees, with sessions evaluating the benefits of the technology. This includes improving imaging interpretation performance and making breast imaging workflows more efficient, as well as how AI can help clinics struggling with staff retention.
Research will also evaluate socioeconomic trends in breast cancer screening, such as how false-positive cases may affect women’s perception of screening and how breast imagers can contribute to global health. And advances in interventional radiology will also be highlighted, such as how image-guided ablation techniques can treat small breast tumors.
The trend of addressing breast density will also continue into this year’s meeting, with sessions exploring how imaging approaches such as MRI or digital breast tomosynthesis (DBT) can help find cancers in women with dense breasts.
Although these innovations might make it seem like conventional mammography is on the wayside, that isn’t the case. A number of sessions will discuss how practice managers can better utilize screening and diagnostic mammography.
RSNA attendees can also explore the technical exhibits for the wide range of technologies that vendors will have on display, including new AI software and mammography, ultrasound, and MRI scanners. In addition, attendees can take advantage of the many educational sessions that will put the spotlight on making personalized and targeted radiological care more efficient. This includes glimpses of what the future may hold for radiologists in women’s imaging and other specialties.
Poster presentations will also encourage attendees to think outside the box about how they can employ emerging imaging technologies and approaches in their practices.
Keep reading for highlights of just some of the many presentations scheduled for this year’s meeting. You can also access the complete scientific and educational program on the RSNA 2025 website. See you in Chicago!
Different breast cancer treatments lead to varied effects on heart health
Sunday, November 30 | 9:00 a.m.-9:10 a.m. | S1-SSNMMI01-1 | Room S405
See this presentation to learn how different chemotherapy regimens affect myocardial accumulation in breast cancer patients, with FDG-PET imaging showing these differences.
Ultrafast MRI parameter time to enhancement better classifies DCIS
Sunday, November 30 | 10:40 a.m.-10:50 a.m. | S2-SSBR01-2 | Room S406A
A multinational team of researchers has found that incorporating the ultrafast MRI parameter time to enhancement, or TTE, into breast MRI exams improves the classification of ductal carcinoma in situ (DCIS) — thus reducing treatment intensity and allowing for more tailored care.
Breast density affects high-risk classification in women
Sunday, November 30 | 2:30 p.m.-2:40 p.m. | S5-SSBR02-1 | Room S406A
Session attendees will learn how volumetric breast density may lead to more women being classified as being at high risk for breast cancer.
AI finds more breast cancers when paired with one radiologist
Monday, December 1 | 3:00 p.m.-3:10 p.m. | M7-SSBR04-1 | Room E451A
Using AI as a standalone reader for screening mammograms when paired with one radiologist leads to more invasive cancers detected and fewer recalls, according to results to be shared in this session.
Black, young women have more false-positive breast screenings
Monday, December 1 | 3:30 p.m.-3:40 p.m. | M7-SSBR04-4 | Room E451A
Visitors can see how false-positive cases affect return to breast cancer screening for women in various subgroups.
Commercial algorithms have varying performance for DBT
Tuesday, December 2 | 9:50 a.m.-10:00 a.m. | T3-SSBR05-3 | Room S406A
Attendees will find out how commercial AI algorithms perform differently when examining digital breast tomosynthesis (DBT) exams.
Can AI improve access, affordability of MRI breast cancer screening?
Tuesday, December 2 | 3:10 p.m.-3:20 p.m. | T7-SSBR07-2 | Room N228
An AI-based MRI protocol can increase the accessibility and cost-effectiveness of breast cancer screening, according to research to be shared on Tuesday afternoon.
Adding DBT to CEM leads to minimal gains
Tuesday, December 2 | 3:20 p.m.-3:30 p.m. | T7-SSBR06-3 | Room S406A
Adding digital breast tomosynthesis (DBT) to contrast-enhanced mammography (CEM) can lead to slightly reduced false-positive recalls, suggest findings to be presented in this session.
Cryoablation safe for treating small breast cancers in older women
Wednesday, December 3 | 9:50 a.m.-10:00 a.m. | W3-SSBR08-3 | Room S406A
Attendees will find out how ultrasound-guided cryoablation is a safe and effective treatment option for elderly women with small, low-risk breast cancer.
Slab reconstruction makes DBT exams more efficient
Thursday, December 4 | 8:00 a.m.-8:10 a.m. | R1-SSBR10-1 | Room S406A
Session attendees will learn about how slab reconstruction technology could help make digital breast tomosynthesis (DBT) exams more efficient.
AI on par with rads in evaluating DBT exams
Thursday, December 4 | 8:20 a.m.-8:30 a.m. | R1-SSBR10-3 | Room S406A
This session will focus on how a commercial AI model can analyze digital breast tomosynthesis (DBT) images as a standalone reader.
Combined DBT plus ultrasound shows trends in age, breast density
Thursday, December 4 | 1:30 p.m.-1:40 p.m. | R6-SSBR11-1 | Room S406A
Attendees for the final day of RSNA can see how breast density metrics for digital breast tomosynthesis (DBT) and whole-breast ultrasound vary with age.